项目详情
  • 项目名称:
    My Life Health Services
  • 项目领域:
    生物医药
  • 联系人姓名:
  • 联系人手机号:
    ***********
项目简介
  • Each year in Australia, 110,000 people have a stroke or heart attack, with 30% of these being a repeat events. Cardiovascular disease (CVD), results in a total economic burden of 7.6 billion dollars annually. In China, 1 in 5, or 290 million people are affected by CVD and it is the leading cause of death (44.6%) annually. This disease burden led to 209.0 billion Yuan (US$26.1 billion) in direct costs in 2003. Cardiovascular events, such as ischemic heart disease and stroke, are projected to increase by 50% among the population between 2010 and 2030 (based on population aging and growth alone). To avoid having a heart attack, it is recommended they complete cardiac rehabilitation. The problem is that 70% of eligible participants do not due to barriers with the community based delivery model. Barriers include transport restrictions, inconvenient program scheduling and locations, long waitlists, variable content and a lack of data and performance monitoring. My Life is a digital behaviour change company that makes chronic disease rehabilitation, prevention and management accessible and engaging. Our unique digital delivery model incorporates social incentives with gamification and health education to provide patients with personalised healthcare. My Life is integrated into the healthcare system to support clinicians to track patient outcomes, individualise care and provide early intervention. Created by health professionals with proven experience in chronic disease rehabilitation and digital behaviour change programs at scale. My Life is supported by our advisory panel including Sean Young, the Executive Director of UCLA's Centre of Digital Behaviour and T im Blake, previously the Chief Information Officer of T asmania Health. We have health providers from across Australia trialling the My Life digital rehabilitation program which will inform the design and grow our future sales funnel. My Life is working with La T robe University and Swinburne University to complete clinical validation of our digital cardiac rehabilitation program. My Life is a software-as-a-service company and hospitals and cardiac rehabilitation (CR) centres as our customers. There are currently 1452 hospitals and 530 cardiac rehabilitation centres in Australia. The total Australian market is estimated at $140M annually. Our target is the 70% of people that currently do not completing cardiac rehabilitation, representing $100M annually. Our market expansion plans include China where we have actively been investigating the market which has 31,000 hospitals who do not have scale-able rehabilitation programs. The largest competitor to My Life are people not completing a cardiac rehabilitation program at all, with 70% of eligible patients unable due to the barriers of the current model. The traditional centre based model is the most prominent cardiac rehabilitation pathway but with less than 30% of people adopting this approach. New models of delivery have developed that include telehealth components such as the Coach Program or Cardihab. These programs integrate the use of digital technology to increase accessibility to information and data capture of patient outcomes but fail to provide sufficient strategies to increase engagement, adherence and accountability,Each year in Australia, 110,000 people have a stroke or heart attack, with 30% of these being a repeat events. Cardiovascular disease (CVD), results in a total economic burden of 7.6 billion dollars annually. In China, 1 in 5, or 290 million people are affected by CVD and it is the leading cause of death (44.6%) annually. This disease burden led to 209.0 billion Yuan (US$26.1 billion) in direct costs in 2003. Cardiovascular events, such as ischemic heart disease and stroke, are projected to increase by 50% among the population between 2010 and 2030 (based on population aging and growth alone). To avoid having a heart attack, it is recommended they complete cardiac rehabilitation. The problem is that 70% of eligible participants do not due to barriers with the community based delivery model. Barriers include transport restrictions, inconvenient program scheduling and locations, long waitlists, variable content and a lack of data and performance monitoring. My Life is a digital behaviour change company that makes chronic disease rehabilitation, prevention and management accessible and engaging. Our unique digital delivery model incorporates social incentives with gamification and health education to provide patients with personalised healthcare. My Life is integrated into the healthcare system to support clinicians to track patient outcomes, individualise care and provide early intervention. Created by health professionals with proven experience in chronic disease rehabilitation and digital behaviour change programs at scale. My Life is supported by our advisory panel including Sean Young, the Executive Director of UCLA's Centre of Digital Behaviour and T im Blake, previously the Chief Information Officer of T asmania Health. We have health providers from across Australia trialling the My Life digital rehabilitation program which will inform the design and grow our future sales funnel. My Life is working with La T robe University and Swinburne University to complete clinical validation of our digital cardiac rehabilitation program. My Life is a software-as-a-service company and hospitals and cardiac rehabilitation (CR) centres as our customers. There are currently 1452 hospitals and 530 cardiac rehabilitation centres in Australia. The total Australian market is estimated at $140M annually. Our target is the 70% of people that currently do not completing cardiac rehabilitation, representing $100M annually. Our market expansion plans include China where we have actively been investigating the market which has 31,000 hospitals who do not have scale-able rehabilitation programs. The largest competitor to My Life are people not completing a cardiac rehabilitation program at all, with 70% of eligible patients unable due to the barriers of the current model. The traditional centre based model is the most prominent cardiac rehabilitation pathway but with less than 30% of people adopting this approach. New models of delivery have developed that include telehealth components such as the Coach Program or Cardihab. These programs integrate the use of digital technology to increase accessibility to information and data capture of patient outcomes but fail to provide sufficient strategies to increase engagement, adherence and accountability

我要反馈